Dalton, Greiner, Hartman, Maher & Co’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-89,472
| Closed | -$489K | – | 58 |
|
|
2021
Q1 | $489K | Sell |
89,472
-149,634
| -63% | -$818K | 0.39% | 111 |
|
|
2020
Q4 | $1.03M | Sell |
239,106
-670,871
| -74% | -$2.88M | 0.22% | 102 |
|
|
2020
Q3 | $2.74M | Sell |
909,977
-749,164
| -45% | -$2.25M | 0.45% | 76 |
|
|
2020
Q2 | $5.14M | Buy |
1,659,141
+39,748
| +2% | +$123K | 0.51% | 76 |
|
|
2020
Q1 | $3.58M | Buy |
1,619,393
+45,412
| +3% | +$100K | 0.37% | 108 |
|
|
2019
Q4 | $4.8M | Buy |
1,573,981
+200,463
| +15% | +$611K | 0.33% | 121 |
|
|
2019
Q3 | $4.22M | Buy |
1,373,518
+218,142
| +19% | +$671K | 0.29% | 124 |
|
|
2019
Q2 | $2.31M | Buy |
1,155,376
+1,067,007
| +1,207% | +$2.13M | 0.19% | 125 |
|
|
2019
Q1 | $381K | Buy |
+88,369
| New | +$381K | 0.03% | 158 |
|